Derivation and assessment of risk prediction models using case-cohort data

BMC Medical Research Methodology

Volumn 13, Issue 1, 2013, Pages

  Sanderson, Jean ^a   Thompson, Simon G ^a   White, Ian R ^b   Aspelund, Thor ^c,d   Pennells, Lisa ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c UNIVERSITY OF ICELAND   (Iceland)

^d ICELANDIC HEART ASSOCIATION   (Iceland)

Author keywords

Cardiovascular disease; Case cohort; Discrimination; Reclassification; Risk prediction

Indexed keywords

ALGORITHM; ARTICLE; CASE CONTROL STUDY; COMPUTER SIMULATION; CORONARY ARTERY DISEASE; HUMAN; INCIDENCE; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL MODEL; CORONARY DISEASE;

ALGORITHMS; CASE-CONTROL STUDIES; COMPUTER SIMULATION; CORONARY DISEASE; DATA INTERPRETATION, STATISTICAL; HUMANS; INCIDENCE; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 84885070420     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-13-113     Document Type: Article

References (28)

1. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Prentince RL, Biometrika 1986 73 1 11 10.1093/biomet/73.1.1
2. Analysis of case-cohort designs. Barlow WE, Ichikawa L, Rosner D, Izumi S, J Clin Epidemiol 1999 52 1165 1172 10.1016/S0895-4356(99)00102-X 10580779 (Pubitemid 29535416)
3. Analysis of case-cohort data: a comparison of different methods. Onland-Moret N, Vandera D, Vanderschouw Y, Buschers W, Elias S, Vangils C, Koerselman J, Roest M, Grobbee D, Peeters P, J Clin Epidemiol 2007 60 350 355 10.1016/j.jclinepi.2006.06.022 17346608 (Pubitemid 46341709)
4. Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease. Ganna A, Reilly M, de Faire U, Pedersen N, Magnusson P, Ingelsson E, Am J Epidemiol 2012 175 715 724 10.1093/aje/kwr374 22396388
5. Estimation of time-dependent area under the ROC curve for long-term risk prediction. Chambless LE, Diao G, Stat Med 2006 25 3474 3486 10.1002/sim.2299 16220486 (Pubitemid 44575164)
6. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK, Boerwinkle E, Mosley TH Jr, Sorlie P, Diao G, et al. Arch Intern Med 2006 166 1368 1373 10.1001/archinte.166.13.1368 16832001 (Pubitemid 44036348)
7. Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. Herder C, Baumert J, Zierer A, Roden M, Meisinger C, Karakas M, Chambless L, Rathmann W, Peters A, Koenig W, et al. PLoS One 2011 6 19852 10.1371/journal.pone.0019852 21674000
8. Literature-based genetic risk scores for coronary heart disease: the Cardiovascular Registry Maastricht (CAREMA) prospective cohort study. Vaarhorst AA, Lu Y, Heijmans BT, Dolle ME, Bohringer S, Putter H, Imholz S, Merry AH, van Greevenbroek MM, Jukema JW, et al. Circ Cardiovasc Genet 2012 5 202 209 10.1161/CIRCGENETICS.111.960708 22373668
9. EPIC-Heart: the cardiovascular component of a prospective study of nutritional, lifestyle and biological factors in 520,000 middle-aged participants from 10 European countries. Danesh J, Saracci R, Berglund G, Feskens E, Overvad K, Panico S, Thompson S, Fournier A, Clavel-Chapelon F, Canonico M, et al. Eur J Epidemiol 2007 22 129 141 10.1007/s10654-006-9096-8 17295097 (Pubitemid 46457303)
10. Evaluating the yield of medical tests. Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA, JAMA 1982 247 2543 2546 10.1001/jama.1982.03320430047030 7069920 (Pubitemid 12155954)
11. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Harrell FE Jr, Lee KL, Mark DB, Stat Med 1996 15 361 387 10.1002/(SICI)1097-0258(19960229)15: 4<361::AID-SIM168>3.0.CO;2-4 8668867 (Pubitemid 26072233)
12. A new measure of prognostic separation in survival data. Royston P, Sauerbrei W, Stat Med 2004 23 723 748 10.1002/sim.1621 14981672 (Pubitemid 38279510)
13. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS, Stat Med 2008 27 157 172 10.1002/sim.2929 17569110 (Pubitemid 351193639)
14. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Pencina MJ, D'Agostino RB Sr, Steyerberg EW, Stat Med 2011 30 11 21 10.1002/sim.4085 21204120
15. Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. Jonsdottir LS, Sigfusson N, Gudnason V, Sigvaldason H, Thorgeirsson G, J Cardiovasc Risk 2002 9 67 76 10.1097/00043798-200204000-00001 12006913 (Pubitemid 34553585)
16. Regression Models and Life-Tables. Cox DR, J R Stat Soc Ser B Methodol 1972 37 187 220
17. Asymptotic distribution theory and efficiency results for case-cohort studies. Self SG, Prentice RL, Ann Stat 1988 16 64 81 10.1214/aos/1176350691
18. Computational methods for case-cohort studies. Langholz B, Jiao J, Comput Stat Data Anal 2007 51 3737 3748 10.1016/j.csda.2006.12.028 (Pubitemid 46509540)
19. Case-cohort design in practice-experiences from the MORGAM Project. Kulathinal S, Karvanen J, Saarela O, Kuulasmaa K, Epidemiol Perspect Innov 2007 4 15 10.1186/1742-5573-4-15 18053196 (Pubitemid 351178233)
20. Assessment and comparison of prognostic classification schemes for survival data. Graf E, Schmoor C, Sauerbrei W, Schumacher M, Stat Med 1999 18 2529 2545 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2529::AID-SIM274>3. 0.CO;2-5 10474158 (Pubitemid 29423514)
21. Explained variation in survival analysis. Schemper M, Stare J, Stat Med 1996 15 1999 2012 10.1002/(SICI)1097-0258(19961015)15:19<1999::AID- SIM353>3.0.CO;2-D 8896135 (Pubitemid 26332293)
22. Assessing the performance of prediction models: a framework for traditional and novel measures. Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW, Epidemiology 2010 21 128 138 10.1097/EDE.0b013e3181c30fb2 20010215
23. Confidence intervals for rank statistics: Somers' D and extensions. Newson R, Stata J 2006 6 309 334 (Pubitemid 44505049)
24. Stata Statistical Software: Release 11 College Station, TX: StataCorp LP 2009
25. Lipid-related markers and cardiovascular disease prediction. The Emerging Risk Factors Collaboration, JAMA 2012 307 2499 2506 22797450
26. C-reactive protein, fibrinogen, and cardiovascular disease prediction. The Emerging Risk Factors Collaboration, NEJM 2012 367 1310 1320 23034020
27. Concordance probability and discriminatory power in proportional hazards regression. Gonen M, Heller G, Biometrika 2005 92 965 970 10.1093/biomet/92.4. 965 (Pubitemid 41681247)
28. Prognostic models with competing risks: methods and application to coronary risk prediction. Wolbers M, Koller MT, Witteman JC, Steyerberg EW, Epidemiology 2009 20 555 561 10.1097/EDE.0b013e3181a39056 19367167